TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LENZ

LENZ Therapeutics Inc

Healthcare · Biotechnology

4.10$ -1.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

LENZ Therapeutics Inc (LENZ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -69 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LENZ
Line item 2019 2020 2021 2022 2023 2024 2025
0.0 -8.7 -53 -88 -60 -59 -69
0.1 0.7 8.3 0.0 0.1 -3.1
0.2 0.7 1.3 6.4 13
0.0 1.7 -2.5 -7.2 9.4 -13 3.3
0.0 1.5 5.7 6.6 0.0 0.5 0.8
-1.5 -5.7 -242 -30 -154 -76
-0.1 -0.1
30 417 0.6 81 199 150
0.0 20 357 -329 -9.3 -15 4.9
0.0 -10 -59 -95 -60 -60 -70

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?